Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing

被引：1
|
作者：
He, Jian [1 ]
Leng, Ai-Min [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷 / 02期
关键词：
FUTURE;
D O I：
10.1002/hep.30603
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：751 / 751
页数：1
相关论文
共 50 条
  • [41] Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD
    Wang, Jian
    Pan, Yifan
    Xiong, Ye
    Wu, Chao
    Huang, Rui
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 978 - 979
  • [42] Changes in fibrosis, but not the NAFLD Activity Score (NAS), are associated with disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis
    Sanyal, A.
    Harrison, S.
    Ratziu, V.
    Abdelmalek, M.
    Diehl, A.
    Caldwell, S.
    Shiffman, M.
    Aguilar, R.
    Jia, C.
    McColgan, B.
    Myers, R.
    Subramanian, M.
    McHutchison, J.
    Muir, A.
    Afdhal, N.
    Bosch, J.
    Goodman, Z.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S2 - S3
  • [43] Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
    Bazick, Jessica
    Donithan, Michele
    Neuschwander-Tetri, Brent A.
    Kleiner, David
    Brunt, Elizabeth M.
    Wilson, Laura
    Doo, Ed
    Lavine, Joel
    Tonascia, James
    Loomba, Rohit
    DIABETES CARE, 2015, 38 (07) : 1347 - 1355
  • [44] Cilofexor and firsocostat treatment is associated with widespread changes in the hepatic transcriptome in NASH patients with advanced fibrosis
    Gindin, Yevgeniy
    Chuang, Jay
    Han, Ling
    Jia, Catherine
    Huss, Ryan
    Chung, Chuhan
    Myers, Robert
    Strasser, Simone
    Wong, Vincent Wai-Sun
    Alkhouri, Naim
    Kowdley, Kris
    Noureddin, Mazen
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2021, 75 : S265 - S265
  • [45] The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression
    Younossi, Zobair M.
    Stepanova, Maria
    Myers, Robert P.
    Younossi, Issah
    Henry, Linda
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 970 - 977
  • [46] EFFECTIVENESS OF NON-INVASIVE TEST SEQUENCING FOR SCREENING PATIENTS WITH MODERATE TO ADVANCED NASH FIBROSIS
    Lazas, Don
    O'Rourke, Joshua
    Pontes, Alda
    Aldous, Mark
    Bachinski, Matthew
    Brown, Michael
    Din, Raja
    Newman, Frederic
    Patel, Pankaj
    Wilson, Louis
    Hoke, Colleen
    Bonnell, Christian
    HEPATOLOGY, 2021, 74 : 952A - 952A
  • [47] The potential role of fatigue in identifying patients with NASH and advanced fibrosis who experience disease progression
    Younossi, Zobair
    Stepanova, Maria
    Myers, Robert
    Al Shabeeb, Reem
    Younossi, Issah
    Henry, Linda
    JOURNAL OF HEPATOLOGY, 2022, 77 : S445 - S446
  • [48] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [49] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [50] REAPPRAISAL OF VITAMIN-E-DEFICIENCY IN PATIENTS WITH CYSTIC-FIBROSIS
    LUDLOW, D
    SPOCK, A
    PEDIATRIC RESEARCH, 1986, 20 (04) : A244 - A244
12345